Merck KGaA (MRCG)

  • A brief financial summary of Merck KGaA as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Select Exchange

Symbol Exchange Currency
MRCG Derived EUR Real-time MRCG Xetra EUR Delayed MRKd BATS Europe EUR Delayed MKKGY OTC Markets USD Delayed 0O14 London EUR Real-time MRCG Milan EUR Real-time MRCG TradeGate EUR Delayed MRCG Frankfurt EUR Delayed MRCG Vienna EUR Real-time
161.40 -0.55 (-0.34%)
Real-time derived data EUR Disclaimer

MRCG Financial Summary

Merck KGaA reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was EUR 5,173 million compared to EUR 5,806 million a year ago. Net income was EUR 739 million compared to EUR 923 million a year ago. Basic earnings per share from continuing operations was EUR 1.7 compared to EUR 2.12 a year ago. Diluted earnings per share from continuing operations was EUR 1.7 compared to EUR 2.12 a year ago.For the nine months, sales was EUR 15,768 million compared to EUR 16,572 million a year ago. Net income was EUR 2,238 million compared to EUR 2,671 million a year ago. Basic earnings per share from continuing operations was EUR 5.15 compared to EUR 6.14 a year ago. Diluted earnings per share from continuing operations was EUR 5.15 compared to EUR 6.14 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
MRCG Income Statement
MRCG
Gross margin TTM 60.22%
Operating margin TTM 20.6%
Net Profit margin TTM 13.5%
Return on Investment TTM 8.53%
Total Revenue
Net Income
Title
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Total Revenue 5,173 5,302 5,293 5,660
Gross Profit 3,011 3,163 3,320 3,408
Operating Income 984 970 1,035 1,427
Net Income 739 704 796 655

Customize

Clear All
0Selected
Please try another search
MRCG Balance Sheet
MRCG
Quick Ratio MRQ 0.79
Current Ratio MRQ 1.56
LT Debt to Equity MRQ 32.1%
Total Debt to Equity MRQ 38.82%
Total Assets
Total Liabilities
Title
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Total Assets 49,906 48,782 48,637 48,526
Total Liabilities 21,611 22,010 22,407 22,521
Total Equity 28,295 26,772 26,230 26,005

Customize

Clear All
0Selected
Please try another search
MRCG Cash Flow Statement
MRCG
Cash Flow/Share TTM 8.62
Revenue/Share TTM 49.28
Operating Cash Flow 14.45%
Cash
Net Change in Cash
Title
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Cash From Operating Activities 1,255 622 853 1,015
Cash From Investing Activities -350 140 -1,231 -246
Cash From Financing Activities -302 -580 124 -498
Net Change in Cash 604 177 -270 250

Customize

Clear All
0Selected
Please try another search

* In Millions of EUR (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles